As the opioid crisis intensifies, Walgreens Boots Alliance (WBA) is facing pressure from a group of stockholder activists to prepare a regular report on how it manages the risk of distributing these addictive prescription painkillers. And a pair of influential shareholder advisory firms is backing the proposal, which will be voted on Friday morning at the Walgreen annual meeting.
The proposal was filed by Investors for Opioid Accountability, a coalition of 53 state treasurers, pension funds, labor funds, and faith-based groups that collectively manage $3.4 trillion in assets. The coalition has targeted more than a dozen drug makers, wholesalers, and retailers in an attempt to change their business practices and account for the misuse and abuse of opioids plaguing the nation.
About the Author Reprints
